Here's the 13-slide pitch deck ReCode Therapeutics used to raise $120 million from OrbiMed and Pfizer to develop new mRNA medicines · page 9 of 13
The slide uses bioluminescence imaging to demonstrate organ-specific targeting (selectivity) and expression levels (potency) across three different species.
Pitch deck · traction · show_traction · overcrowded density
Slide locked Sign in to view
Slide schematic 8/8
image 3/3 list 3/3 paragraph 1/1 title 1/1
Components 8
infographic infographic infographic bullet bullet bullet paragraph headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.